NIH-funded research R01 grant

New ways to reduce heart damage from pneumonia infections

Official title: Novel strategies to mitigate cardiac damage and dysfunction following invasive pneumococcal disease

Funded at University of Alabama at Birmingham · NIH-11094885 · Data updated 2026-11-12

This study is looking at how pneumonia from a specific bacteria can cause heart issues in adults, and it aims to find ways to protect the heart and help people recover better after pneumonia.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Alabama at Birmingham
NIH-funded
Lab location1 site (Birmingham, United States)
Project startMay 25, 2024
Project endApril 30, 2028
Funding year2025
Award (this year)$645,107
NIH project number5R01HL171136-02
Project IDNIH-11094885 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults who have been hospitalized for community-acquired pneumonia and are at risk for heart complications.

Less likely to help

Patients who have not been hospitalized for pneumonia or those with pre-existing severe heart conditions may not benefit from this research.

What this research studies

This research investigates how pneumonia, specifically caused by the bacterium Streptococcus pneumoniae, can lead to serious heart problems in adults. It aims to identify strategies to reduce cardiac damage and dysfunction that often follow pneumonia infections. By studying the body's inflammatory response and signaling pathways involved in heart injury, the research seeks to develop potential treatments that could improve heart health in patients recovering from pneumonia. The approach includes both laboratory studies and potential clinical applications.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that protect the heart from damage during and after pneumonia infections.

How similar studies have gone: While there has been significant research on pneumonia's effects on the respiratory system, this specific focus on cardiac damage is relatively novel and has not been extensively tested.

Where this research is happening

  • University of Alabama at Birmingham
    Birmingham, United States
    Active

Researchers

  • Principal investigator: Lal, Hind — University of Alabama at Birmingham
  • Study coordinator: Lal, Hind

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.